NCT00003771View on ClinicalTrials.gov

Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

1,300

Participants

Timeline

Start Date

September 30, 1997

Study Completion Date

February 29, 2004

Conditions
Breast CancerMenopausal Symptoms
Interventions
BIOLOGICAL

therapeutic estradiol

DRUG

norethindrone acetate

Trial Locations (6)

FIN-00029

Helsinki University Central Hospital, Helsinki

N-0310

Norwegian Radium Hospital, Oslo

02-781

Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw

S-171 76

Karolinska Hospital, Stockholm

S-75185

Uppsala University Hospital, Uppsala

CH-8008

Breast Center, Zurich

All Listed Sponsors
collaborator

Scandinavian Breast Group

OTHER

collaborator

ETOP IBCSG Partners Foundation

NETWORK

collaborator

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

lead

Regional Oncologic Center

OTHER

NCT00003771 - Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer | Biotech Hunter | Biotech Hunter